OYAVAS
Concentrate for solution for infusion, 25mg/ml
RxActive license
Active substance (INN)
bevacizumab
Pharmaceutical form
Pharmaceutical formConcentrate for solution for infusion
Strength25mg/ml
PackagingUkupno 1 bočica staklena sa 4ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerGH Genhelix S.A., Spain
Therapeutic groupAntineoplastic and immunomodulating agents (L01FG01)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateMay 26, 2022
Analogs in Montenegro
7Other medicines with the same active substance
ALYMSYSRx
Concentrate for solution for infusion, 25mg/mlALYMSYSRx
Concentrate for solution for infusion, 400mg/16mlAVASTINRx
Concentrate for solution for infusion, 25mg/mlAVASTINRx
Concentrate for solution for infusion, 25mg/mlOYAVASRx
Concentrate for solution for infusion, 25mg/mlZirabevRx
Concentrate for solution for infusion, 25mg/mlZirabevRx
Concentrate for solution for infusion, 25mg/mlSource: CInMED register